Article
DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications
5 Jun 2020
Abstract excerpt
BACKGROUND: Pancreatic cancer or pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating cancer types with a 5-year survival rate of only 9%. PDAC is one of the leading causes of cancer-related deaths in both genders. Epigenetic alterations may lead to the suppression of tumor suppressor genes, and DNA methylation is a predominant epigenetic modification. DNA methyltransferase 1 (DNMT1) is required...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
